CancerNCT07724041
Feasibility of a Real-world, Financial Psycho-oncology Intervention to Address Cancer-related Financial Distress
A study testing Financial psycho-oncology intervention in people with Cancer and Financial Hardship, run by University of Alabama at Birmingham at 1 site in United States.
Trial summary
The goal of this pilot, feasibility study is to evaluate the feasibility and preliminary impact of a finance-specific psycho-oncology intervention, as well as to explore perceptions of and experiences with this financial psycho-oncology intervention for patients with cancer experiencing financial hardship. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Cancer, Financial Hardship, Psychological Distress
- What is being tested?
- Financial psycho-oncology intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Sep 2026to Aug 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adult patients with cancer receiving treatment at the UAB Medical Oncology and/or UAB Supportive Care clinics
Who cannot join
- non-English speakers
- patients with non-melanoma skin cancers
- patients with dementia/cognitive impairments
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
University of Alabama at Birmingham
Birmingham, Alabama, 35233
Hayden Reeves, 205-996-4109, haydenreeves@uabmc.edu
Courtney Williams, DrPH
About this study
The goal of this pilot, feasibility study is to evaluate the feasibility and preliminary impact of a finance-specific psycho-oncology intervention, as well as to explore perceptions of and experiences with this financial psycho-oncology intervention for patients with cancer experiencing financial hardship. The main questions it aims to answer are:
- Is this financial psycho-oncology intervention feasible, acceptable, and appropriate for patients with cancer experiencing financial hardship?
- How can we refine the financial psycho-oncology intervention to best address financial distress for patients with cancer experiencing financial hardship?
Patients enrolled in the intervention will receive 2, 60-minute long, finance-specific psycho-oncology sessions per month over the course of 3 months, for a total of 6 sessions over the course of the intervention. Patients will complete surveys during intervention enrollment and after intervention completion to assess secondary outcomes of financial hardship, psychological distress, stress, and anxiety. Individuals who consent to the financial psycho-oncology intervention will also be invited to participate in a 30-minute semi-structured interview to explore their perceptions of and experiences with the financial psycho-oncology intervention, including concepts of participation and engagement, relevance and acceptability, content and understanding, logistics and practicality, and potential impact.
- Conditions
- Cancer, Financial Hardship, Psychological Distress
- Being tested
- Financial psycho-oncology intervention
- Medical subject headings
- Neoplasms, Financial Stress
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Financial psycho-oncology interventionBehavioural
Program which integrates emotional support, coping strategies, and financial psychoeducation to enhance patients' capacity to cope with both their emotional and financial burdens due to cancer.
| Study group | Role | What they receive |
|---|---|---|
| Patients receiving financial psycho-oncology intervention | Experimental | Not described Receives: Behavioral: Financial psycho-oncology intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Recruitment as a measure of feasibility
50% of contacted patients consenting to participate
Measured: From enrollment to the end of the financial psycho-oncology intervention at 3 months
Retention as a measure of feasibility
70% of consenting patients completing the program per protocol
Measured: From enrollment to the end of the financial psycho-oncology intervention at 3 months
Completion as a measure of feasibility
<15% missing survey data
Measured: From enrollment to the end of the financial psycho-oncology intervention at 3 months
Secondary outcomes (5)
Change in Financial hardship
as measured by COmprehensive Score for financial Toxicity (COST)
Measured: From enrollment to the end of the financial psycho-oncology intervention at 3 months
Change in Psychological distress
as measured by National Comprehensive Cancer Network Distress Thermometer and Problem List
Measured: From enrollment to the end of the financial psycho-oncology intervention at 3 months
Change in Perceived stress
as measured by Perceived Stress Scale (PSS-10)
Measured: From enrollment to the end of the financial psycho-oncology intervention at 3 months
Change in Anxiety
as measured by PROMIS Emotional Distress - Anxiety - Short Form 4
Measured: From enrollment to the end of the financial psycho-oncology intervention at 3 months
Change in Depression
as measured by PROMIS Emotional Distress - Depression - Short Form 4
Measured: From enrollment to the end of the financial psycho-oncology intervention at 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jul 2026
- Study start1 Sep 2026
- Primary completionMay 2027 (estimated)
- Study completionAug 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- More trials run by University of Alabama at BirminghamThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 20 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Alabama at Birmingham
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Courtney Williams, University of Alabama at Birmingham
- Investigators
- Courtney Williams, DrPH, Principal investigator, University of Alabama at Birmingham
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07724041
- Sponsor's protocol ID
- PREP_Williams2026
- Other IDs
- UAB
- Status last verified
- Sep 2026
- First submitted
- 16 Jul 2026
- Last updated
- 5 Oct 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No